A study using SpyBiotech’s vaccine technology shows its potential against Covid-19 and other Coronaviruses

Read more

SpyBiotech announces the appointment of Simon Jones as VP, Finance and Operations and expansion of the scientific team

Read more

SpyBiotech featured in The Guardian Value of Vaccines supplement

Read more

SpyBiotech announces the appointments of Dan Menichella as Non-Executive Director and Dr Norman Begg as Scientific Advisor

Read more

SpyBiotech raises $32.5M in Series A funding and appoints Lutz B. Giebel as Chairman

Read more

Study from Scripps using SpyTag/SpyCatcher for display of SARS-CoV-2 RBD on ferritin nanoparticles for vaccine development

Read more

SpyBiotech and Serum Institute of India announce that the first subjects have been dosed in a Phase I/II trial of a novel virus-like particle vaccine targeting COVID-19

Read more

Covid-19 vaccine candidates using SpyCatcher/SpyTag to display Spike protein on computationally designed particles and Bacteriophage VLPs

Read more